CPT code 0268U: aHUS genetic test, 15-gene sequence analysis2026 Medicare lab fee · Clinical Laboratory Fee Schedule
This 15-gene genomic sequence analysis detects abnormalities associated with atypical hemolytic uremic syndrome and is associated with blood, buccal swab, or amniotic fluid specimens.
Medicare pays $608.17 for 0268U under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$608.17
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2023
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 7 sections
What 0268U covers
0268U identifies abnormalities associated with atypical hemolytic uremic syndrome (aHUS) through genomic sequence analysis of 15 genes. The associated specimens are blood, buccal swab, and amniotic fluid. The defining service is the 15-gene analysis; the specimen alone does not identify the test.
Report 0268U for this specific analysis, rather than selecting it solely from the patient's diagnosis. Medicare pays the code through the CLFS at one nationally priced amount that applies across states and localities, without geographic or office/facility adjustment. The 2026 national amount is $608.17, unchanged from 2023 through 2026. The code is paid only through the CLFS and has no physician fee schedule payment.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 0268U
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 0268U. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Not on the physician fee schedule
The physician fee schedule doesn’t list 0268U: Medicare pays the test only from the CLFS.
0268U on the lab fee schedule since 2021
0268U · CLFS 2026 Q4 (current)
$608.17
Unchanged since Jan 1, 2023
Every change on file
- Jan 1, 2023 · CLFS 2023 Q1MAC-priced → $608.17
21 quarterly CLFS releases on file, first CLFS 2021 Q4. A code missing from a quarter wasn’t on that release.
0268U compared with similar tests
- 0269UGene analysis22-gene thrombocytopenia panel$608.17
- Choose 0268U for the 15-gene analysis associated with aHUS. Code 0269U describes a separate hematology genetic assay involving autoimmune disease and congenital thrombocytopenia.
- 0265UGenome sequencingRare heritable disorders$5,475.80
- 0265U describes rare-disease whole-genome and mitochondrial DNA analysis. 0268U is the targeted 15-gene genomic sequence analysis associated with aHUS.
- 0267UGenome testMapping plus sequencing$6,739.33
- 0267U involves rare-disease identification using optical genome mapping and sequencing. 0268U identifies the specific 15-gene analysis associated with aHUS.
0268U billing questions
Which specimens are associated with this test?
The test is associated with blood, buccal swab, or amniotic fluid. Report 0268U for the specified 15-gene analysis, not based on specimen type alone.
Should this code be selected based only on an aHUS diagnosis?
No. Report 0268U when the laboratory performs the 15-gene genomic sequence analysis for abnormalities associated with aHUS.
How does 0268U differ from 0269U?
0268U is the 15-gene analysis for abnormalities associated with aHUS. 0269U describes a different hematology genetic assay involving autoimmune disease and congenital thrombocytopenia.
How does Medicare pay for 0268U?
Medicare pays 0268U through the CLFS at one national amount across states and localities, with no office or facility difference. The code has no physician fee schedule payment.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 0268U and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist